Regeneron Pharmaceuticals, Inc. today announced that results from the National Institutes of Health-sponsored, Diabetic Retinopathy Clinical Research Network comparative effectiveness study in patients with Diabetic Macular Edema (Protocol T) were published in the New England Journal of Medicine and a corresponding slide set was posted online at DRCR.net.
from The Medical News http://ift.tt/1zSrV3d
from The Medical News http://ift.tt/1zSrV3d
No comments:
Post a Comment